AISLING CAPITAL III LP Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for AISLING CAPITAL III LP.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of AISLING CAPITAL III LP. AISLING CAPITAL III LP is a 10% Owner in AGILE THERAPEUTICS INC ($AGRX) and a 10% Owner in T2 Biosystems, Inc. ($TTOO) and a 10% Owner in Syros Pharmaceuticals, Inc. ($SYRS) and a 10% Owner in Loxo Oncology, Inc. ($LOXO).
Address: 888 SEVENTH AVENUE THIRTIETH FLOOR NEW YORK 10106 NY
Companies in which AISLING CAPITAL III LP is an Insider
AGILE THERAPEUTICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AISLING CAPITAL III LP: 10% Owner
Holdings: 2,583,797 shares
Current Value: $6,123,599
Latest Transaction: Jun 03 2016
$AGRX Market Capitalization: $65.57M
$AGRX Previous Close: $2.37
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AISLING CAPITAL III LP: 10% Owner
Holdings: 2,038,920 shares
Current Value: $80,945,124
Latest Transaction: Jul 12 2018
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Syros Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of AISLING CAPITAL III LP: 10% Owner
Holdings: 508,565 shares
Current Value: $5,553,530
Latest Transaction: Jul 06 2016
$SYRS Market Capitalization: $249.93M
$SYRS Previous Close: $10.92
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
T2 Biosystems, Inc.
Industry: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
Position of AISLING CAPITAL III LP: 10% Owner
Holdings: 2,830,992 shares
Current Value: $15,966,795
Latest Transaction: Dec 09 2015
$TTOO Market Capitalization: $170.72M
$TTOO Previous Close: $5.64
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of AISLING CAPITAL III LP
Sentiment: All, AGRX, LOXO, SYRS, TTOO
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jul 12 2018 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 179.43 | 1,400,000 | 251,202,000 | 2,038,920 | 3.4 M to 2 M (-40.71 %) |
| Dec 20 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 80.50 | 250,000 | 20,125,000 | 3,438,920 | 3.7 M to 3.4 M (-6.78 %) |
| Nov 27 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Sell | S | 75.00 | 500,000 | 37,500,000 | 3,688,920 | 4.2 M to 3.7 M (-11.94 %) |
| Jan 12 2017 | LOXO | Loxo Oncology, Inc ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 31.00 | 160,000 | 4,960,000 | 4,188,920 | 4 M to 4.2 M (+3.97 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Option Exercise | C | 0.00 | 1,907,122 | 0 | 0 | |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | P | 12.50 | 400,000 | 5,000,000 | 908,565 | 508.6 K to 908.6 K (+78.65 %) |
| Jul 06 2016 | SYRS | Syros Pharmaceutic ... | AISLING CAPITAL III LP | 10% Owner | Buy | C | 0.00 | 508,565 | 0 | 508,565 | 0 to 508.6 K |